Patents by Inventor Robert Reder

Robert Reder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INVERTER HAVING PROGRAMMING INTERFACE
    Publication number: 20160231995
    Abstract: Inverter for converting a DC voltage to an AC voltage, comprising an inverter controller which is connected to a programming interface of the inverter via which inverter software components can be downloaded.
    Type: Application
    Filed: May 14, 2014
    Publication date: August 11, 2016
    Inventors: Robert Reder, Ernst Baumgartinger, Christoph Mayer, Joachim Jungreithmeier, Peter Kardos
  • DISABLING THE INVERTER OF A PHOTOVOLTAIC INSTALLATION IN THE EVENT OF THEFT
    Publication number: 20150162748
    Abstract: A method for operating an inverter (1) of a photovoltaic installation is specified, wherein a reference value/reference profile of at least one parameter of the photovoltaic installation is compared with an actual value/actual profile of said parameter. If the deviation between said actual value/actual profile and the reference value/reference profile exceeds a predefinable threshold, then the inverter function of the inverter (1) is at least temporarily disabled. Furthermore, an inverter (1) for carrying out said method is specified.
    Type: Application
    Filed: June 10, 2013
    Publication date: June 11, 2015
    Applicant: Fronius International GmbH
    Inventors: Robert Reder, Stefan Martetschlaeger, Mark Koller, Gerald Bart, Florian Schuster, Roland Lecher
  • Method of providing sustained analgesia with buprenorphine
    Publication number: 20060216340
    Abstract: A method of effectively treating pain in humans is achieved by administering buprenorphine in accordance with first order kinetics over an initial three-day dosing interval, such that a maximum plasma concentration from about 20 pg/ml to about 1052 pg/ml is attained, and thereafter maintaining the administration of buprenorphine for at least an additional two-day dosing interval in accordance with substantially zero order kinetics, such that the patients experience analgesia throughout the at least two-day additional dosing interval.
    Type: Application
    Filed: May 26, 2006
    Publication date: September 28, 2006
    Inventors: Robert Reder, Paul Goldenheim, Robert Kaiko